Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment.

作者: Shamila Mauiyyedi , Robert B. Colvin

DOI: 10.1097/00041552-200211000-00007

关键词:

摘要: Purpose of reviewEvidence from several transplant centers indicates that a substantial proportion acute and chronic renal allograft rejection is caused by antibodies to donor antigens. Antibody-mediated injury arises despite potent anti-T cell pharmacological agents, probably requires differe

参考文章(41)
PHILIP F. HALLORAN, JOY SCHLAUT, KIM SOLEZ, NANGALI S. SRINIVASA, The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation. ,vol. 53, pp. 550- 555 ,(1992) , 10.1097/00007890-199203000-00011
Ivan Damjanov, Pathology of the Liver Modern Pathology. ,vol. 15, pp. 278- 278 ,(2002) , 10.1038/MODPATHOL.3880523
E E Schneeberger, S L Saidman, A B Cosimi, N Tolkoff-Rubin, R B Colvin, M A Pascual, W W Williams, A B Collins, Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. Journal of The American Society of Nephrology. ,vol. 10, pp. 2208- 2214 ,(1999) , 10.1681/ASN.V10102208
B. YARD, M. SPRUYT-GERRITSE, F. CLAAS, J. THOROGOOD, J. A. BRUIJN, M. E. PAAPE, S. Y. STEIN, L. A. VAN ES, J. H. VAN BOCKEL, M. KOOYMANS-COUTINHO, M. R. DAHA, F. J. VAN DER WOUDE, The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation. ,vol. 55, pp. 1287- 1293 ,(1993) , 10.1097/00007890-199306000-00015
Manuel Pascual, Tom Theruvath, Tatsuo Kawai, Nina Tolkoff-Rubin, A. Benedict Cosimi, Strategies to improve long-term outcomes after renal transplantation. The New England Journal of Medicine. ,vol. 346, pp. 580- 590 ,(2002) , 10.1056/NEJMRA011295
Tom P. Theruvath, Susan L. Saidman, Shamila Mauiyyedi, Francis L. Delmonico, Winfred W. Williams, Nina Tolkoff-Rubin, A. Bernard Collins, Robert B. Colvin, A. Benedict Cosimi, Manuel Pascual, Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation. ,vol. 72, pp. 77- 83 ,(2001) , 10.1097/00007890-200107150-00016
Michael L.X. Fu, Hans Herlitz, Wolfgang Schulze, Gerd Wallukat, Patrick Micke, Pierre Eftekhari, Klas-Göran Sjögren, Åke Hjalmarsona, Werner Müller-Esterl, Johan Hoebeke, Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension Journal of Hypertension. ,vol. 18, pp. 945- 953 ,(2000) , 10.1097/00004872-200018070-00017
Juan M. Aranda, Juan C. Scornik, Sigurd J. Normann, Richard Lottenberg, Richard S. Schofield, Daniel F. Pauly, Maureen Miles, James A. Hill, John W. Sleasman, Suzanne Skoda-Smith, Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation. ,vol. 73, pp. 907- 910 ,(2002) , 10.1097/00007890-200203270-00013
Robert W. Steiner, Connie Davis, Dolly B. Tyan, Stanley C. Jordan, Adrianus W. Quartel, Lawrence S.C. Czer, Dan Admon, Ge Chen, Michael C. Fishbein, Jeremy Schwieger, Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation. ,vol. 66, pp. 800- 805 ,(1998) , 10.1097/00007890-199809270-00017